Partnerships
Pfizer Begins Phase 2 Of Diabetes Drug, Triggering $10 Million Milestone To Sosei Heptares
2022-12-22
Regeneron Pays CytomX $2 Billion Biobucks to Develop Bispecific Cancer Therapies Together
2022-11-17